Home > Share Market > Stocks > Sms pharmaceuticals > Financial Statements > SMSPHARMA Key Financial Ratios

Sms pharmaceuticals Financial Statements

Sms pharmaceuticals Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 36.70 (11) 5.60 (27)
Op profit growth 51.50 (14) 24.80 (16)
EBIT growth 62.40 (17) 32.90 (22)
Net profit growth 98 (0.60) 11.50 (30)
Profitability ratios (%)        
OPM 21.50 19.40 20.20 17.10
EBIT margin 18.20 15.30 16.40 13
Net profit margin 11.10 7.66 6.86 6.50
RoCE 15.90 12.20 16.50 11.50
RoNW 4.12 2.50 2.94 2.60
RoA 2.44 1.53 1.72 1.44
Per share ratios ()        
EPS 7.20 3.86 4.78 4.21
Dividend per share 0.30 0.25 0.25 0.20
Cash EPS 4.75 1.12 1.40 1.10
Book value per share 48.50 41.10 33.60 30.10
Valuation ratios        
P/E 17.30 6.90 15.40 20.40
P/CEPS 26.20 23.70 52.60 77.90
P/B 2.57 0.65 2.19 2.85
EV/EBIDTA 10.20 4.39 7.91 11.30
Payout (%)        
Dividend payout -- -- 6.67 5.94
Tax payout (33) (36) (33) (14)
Liquidity ratios        
Debtor days 50.10 32.30 17.90 34.30
Inventory days 86.50 105 78.90 85.50
Creditor days (54) (49) (53) (82)
Leverage ratios        
Interest coverage (9.20) (5.20) (4.90) (3.70)
Net debt / equity 0.52 0.42 0.47 0.54
Net debt / op. profit 1.77 1.84 1.43 1.83
Cost breakup ()        
Material costs (60) (60) (63) (68)
Employee costs (7.30) (9.60) (7.10) (6.10)
Other costs (11) (11) (10) (9.30)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000